Insider Trading History of Mizel Adam

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Mizel Adam since 2007. The trader's CIK number is 1079310. At the time of the last reporting, Mizel Adam was the Director of Cinedigm Corp.. (stock ticker symbol CIDM). Also see all insider trading activities at Cinedigm Corp..

Note that in the past Mizel Adam also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pacifichealth Laboratories Inc (PHLI) by Mizel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 PHLI 10,000 $2,450 0 $0 0 $0
2007 PHLI 68,500 $60,097 0 $0 0 $0

Yearly summary of insider trading at Cinedigm Corp. (CIDM) by Mizel Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 CIDM 37,721 $59,599 37,721 $59,599 0 $0


Insider trading activities at 2 companies by Mizel Adam:

1. Pacifichealth Laboratories Inc (PHLI)

2. Cinedigm Corp. (CIDM)

Table 1. Insider trading of Pacifichealth Laboratories Inc (PHLI) by Mizel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-09-04 PHLI Buy 5,000 .24 1,200
2009-09-08 PHLI Buy 5,000 .25 1,250
2007-12-04 PHLI Buy 9,000 .73 6,597
2007-12-05 PHLI Buy 6,000 .70 4,200
2007-11-30 PHILI Buy 50,000 .83 41,550
2007-08-17 PHLI Buy 1,000 2.25 2,250
2007-08-16 PHLI Buy 2,500 2.20 5,500

Table 2. Insider trading of Cinedigm Corp. (CIDM) by Mizel Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-11-28 CIDM Sale 37,721 1.58 59,599
2012-11-28 CIDM Buy 37,721 1.58 59,599

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mizel Adam (Director of Cinedigm Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.